NERV
Price
$2.59
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
31 days until earnings call
SWTX
Price
$31.83
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
27 days until earnings call
Ad is loading...

NERV vs SWTX

Header iconNERV vs SWTX Comparison
Open Charts NERV vs SWTXBanner chart's image
Minerva Neurosciences
Price$2.59
Change-$0.00 (-0.00%)
Volume$11.77K
CapitalizationN/A
SpringWorks Therapeutics
Price$31.83
Change-$0.00 (-0.00%)
Volume$729.63K
CapitalizationN/A
View a ticker or compare two or three
NERV vs SWTX Comparison Chart
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NERV vs. SWTX commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NERV is a StrongBuy and SWTX is a Sell.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (NERV: $2.59 vs. SWTX: $31.83)
Brand notoriety: NERV and SWTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NERV: 73% vs. SWTX: 79%
Market capitalization -- NERV: $18.57M vs. SWTX: $2.4B
NERV [@Biotechnology] is valued at $18.57M. SWTX’s [@Biotechnology] market capitalization is $2.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NERV’s FA Score shows that 0 FA rating(s) are green whileSWTX’s FA Score has 0 green FA rating(s).

  • NERV’s FA Score: 0 green, 5 red.
  • SWTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both NERV and SWTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 3 TA indicator(s) are bullish while SWTX’s TA Score has 4 bullish TA indicator(s).

  • NERV’s TA Score: 3 bullish, 5 bearish.
  • SWTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both NERV and SWTX are a bad buy in the short-term.

Price Growth

NERV (@Biotechnology) experienced а -4.78% price change this week, while SWTX (@Biotechnology) price change was -1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

NERV is expected to report earnings on Nov 04, 2024.

SWTX is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SWTX($2.4B) has a higher market cap than NERV($18.6M). SWTX YTD gains are higher at: -12.795 vs. NERV (-57.886). NERV has higher annual earnings (EBITDA): -24.78M vs. SWTX (-318.71M). SWTX has more cash in the bank: 384M vs. NERV (30.9M). NERV has less debt than SWTX: NERV (0) vs SWTX (7.06M). SWTX has higher revenues than NERV: SWTX (86.2M) vs NERV (0).
NERVSWTXNERV / SWTX
Capitalization18.6M2.4B1%
EBITDA-24.78M-318.71M8%
Gain YTD-57.886-12.795452%
P/E RatioN/AN/A-
Revenue086.2M-
Total Cash30.9M384M8%
Total Debt07.06M-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERVSWTX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 22 days ago
79%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
NERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRMAX10.52N/A
N/A
Voya Russell Mid Cap Index Port A
FZALX24.95-0.03
-0.12%
Fidelity Advisor Mega Cap Stock Z
SNPTX18.09-0.03
-0.17%
DWS Equity Sector Strategy Institutional
IVVIX19.18-0.06
-0.31%
Delaware Ivy Smid Cap Core Fund Class I
MEIKX53.46-0.32
-0.60%
MFS Value R6

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with SYRE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-4.08%
SYRE - NERV
35%
Loosely correlated
+2.49%
MIST - NERV
27%
Poorly correlated
N/A
OCUP - NERV
27%
Poorly correlated
-3.01%
SWTX - NERV
26%
Poorly correlated
-3.05%
ATOS - NERV
24%
Poorly correlated
-4.08%
More

SWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SWTX has been loosely correlated with BCRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SWTX jumps, then BCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWTX
1D Price
Change %
SWTX100%
-3.05%
BCRX - SWTX
42%
Loosely correlated
+0.54%
RNA - SWTX
42%
Loosely correlated
-0.15%
DAWN - SWTX
41%
Loosely correlated
+1.32%
RCUS - SWTX
41%
Loosely correlated
-0.52%
CHRS - SWTX
40%
Loosely correlated
+1.96%
More